Table 3 Number of discordances between the OSEM1/OSEM2 scenario and other scenarios involving reconstruction inconsistency for EORTC and PERCIST therapeutic evaluations
Numbers of discordances n (%) | ||
|---|---|---|
EORTC | PERCIST | |
OSEMPET1/OSEMPET2 vs OSEMPET1/ PSF ± TOFPET2 | 19 (31) | 10 (16) |
OSEMPET1/OSEMPET2 vs PSF ± TOFPET1/OSEMPET2 | 17 (28) | 11 (18) |
OSEMPET1/OSEMPET2 vs OSEMPET1/ PSF ± TOF.EQPET2 | 2 (3) | 2 (3) |
OSEMPET1/OSEMPET2 vs PSF ± TOF.EQPET1/OSEMPET2 | 3 (5) | 0 (0) |
OSEMPET1/OSEMPET2 vs PSF ± TOFPET1/ PSF ± TOFPET2 | 6 (10) | 3 (5) |
OSEMPET1/OSEMPET2 vs PSF ± TOF.EQPET1/ PSF ± TOF.EQPET2 | 3 (5) | 3 (5) |